维普中文期刊产品整合服务
24篇 您的检索式:作者名="Wong MN"
    题名 作者 年代 出处 被引量
1Short term outcomes of minimally invasive selective lateral pelvic lymph node dissection for low rectal cancer显示文摘BACKGROUND Pelvic recurrence after rectal cancer surgery is still a significant problem despite the introduction of total mesorectal excision and chemoradiation treatment(CRT),and one of the most common areas of recurrence is in the lateral pelvic lymph nodes.Hence,there is a possible role for lateral pelvic lymph node dissection(LPND)in rectal cancer.AIM To evaluate the short-term outcomes of patients who underwent minimally invasive LPND during rectal cancer surgery.Secondary outcomes were to evaluate for any predictive factors to determine lymph node metastases based on pre-operative scans.METHODS From October 2016 to November 2019,22 patients with stage II or III rectal cancer underwent minimally invasive rectal cancer surgery and LPND.These patients were all discussed at a multidisciplinary tumor board meeting and most of them received neoadjuvant chemoradiation prior to surgery.All patients had radiologically positive lateral pelvic lymph nodes on the initial staging scans,defined as lymph nodes larger than 7 mm in long axis measurement,or abnormal radiological morphology.LPND was only performed on the involved side.RESULTS Majority of the patients were male(18/22,81.8%),with a median age of 65 years(44-81).Eighteen patients completed neoadjuvant CRT pre-operatively.18 patients(81.8%)had unilateral LPND,with the others receiving bilateral surgery.The median number of lateral pelvic lymph nodes harvested was 10(3-22)per pelvic side wall.8 patients(36.4%)had positive metastases identified in the lymph nodes harvested.The median pre-CRT size of these positive lymph nodes was 10 mm.Median length of stay was 7.5 d(3-76),and only 2 patients failed initial removal of their urinary catheter.Complication rates were low,with only 1 lymphocele and 1 anastomotic leak.There was only 1 mortality(4.5%).There have been no recurrences so far.CONCLUSION Chemoradiation is inadequate in completely eradicating lateral wall metastasis and there are still technical limitations in accurately diagnosing metastases in these areas.A pre-CRT lymph node size of≥10 mm is suggestive of metastases.LPND may be performed safely with minimally invasive surgery.Kar Yong Wong Aloysius MN Tan 2020World Journal of Gastrointestinal Surgery2020,12,4:4
2Whole brain radiotherapyfor the treatment of newly diagnosed multiple brain metastases显示文摘Tsao MN Lloyd N Wong RKS 2012Cochrane Database Syst Rev2012,4,00:1
3Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases显示文摘Tsao MN Lloyd N Wong RK 2012Cochrane Database Syst Rev2012,4,:1
4Radiotherapeutic management of brain metastases: a systematic review and meta-analysis显示文摘Tsao MN Lloyd NS Wong RK 2005Cancer Treat Rev2005,31,4:1
5Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases显示文摘Tsao MN Lloyd N Wong RK 0,,04:1
6Radiotherapeutic management of brain metastases: a systematic review and meta- analysis显示文摘Tsao MN Lloyd NS Wong RK 2005Cancer Treat Rev2005,31,4:1
7Regulation of human Th9 differentiation by type I interferons and IL-21显示文摘Wong MT Ye JJ Alonso MN 2010Im- munol Cell Biol2010,88,:1
8Radiotherapeutic management of brain metastases: A systematic review and meta-analysis显示文摘Tsao MN Lloyd NS Wong RK 2005Cancer Treat Rev2005,31,4:1
9Regulation of human Th9 differentiation by type Ⅰ interferons and IL-21显示文摘Wong MT Ye JJ Alonso MN 2010Immunol Cell Biol2010,88,6:1
10Radiotherapeutic man?agement of brain metastases: a systematic review and meta?analysis显示文摘Tsao MN lloyd NS Wong RK 2005Cancer Treat Rev2005,31,:1
11Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery显示文摘Kirchhof B Wong D Meurs JV Hilgers RD Lois MN Schrage NF 2002Am J Ophthalmol2002,130,2:1
12Supportive care guidelines group of cancer care ontario's program in evidence-based care clinical practice guideline on the optimal radiotherapeutic management of brain metastases显示文摘Tsao MN Lioyd NS Wong RK 2005BMC Cancer2005,5,1:1
13Regulation of human Th9differentiation by type I interferons and IL-21 显示文摘Wong MT Ye JJ Alonso MN 2010Immunol CellBiol2010,,:1
14Radiotherapeutic management of brain metastases:a systematic review and meta-analysis显示文摘Tsao MN Lloyd NS Wong RK 2005Cancer Treat Rev2005,31,4:1
15THI, TH2, and TH17 cells instruct monocytes to differentiate into specialized dendritic cell subsets显示文摘Alonso MN Wong MT Zhang AL 2011Blood2011,118,12:1
16Regulation of human Th9 dif-ferentiation by typeⅠinterferons and IL-21显示文摘Wong MT Ye JJ Alonso MN 2010Immunol CellBiol2010,88,6:1
17Treatment of neuroendocrine tumours in adults with 131I-MIBG therapy显示文摘Bomanji JB Wong W Gaze MN 2003Clin Oncol(R Coll Radiol)2003,15,4:1
18Radiofrequency catheter ablation in the treatment of supraventricular tachycardia in the elderly显示文摘Epstein LM Chiesa N Wong MN 1994JACC1994,23,:1
19Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases 显示文摘Tsao MN Lloyd N Wong RK 2012Cochrane Database Syst Rev2012,18,4:1
20Radiofrequency catheter ablation in the treatment of supraventricular tachycardia in the elderly显示文摘Epstein LM Chiesa N Wong MN 1994J Am Coll Cardiol1994,23,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费